Logo image of IMAX

IMAX CORP (IMAX) Stock Fundamental Analysis

NYSE:IMAX - New York Stock Exchange, Inc. - CA45245E1097 - Common Stock - Currency: USD

24.76  +0.11 (+0.45%)

After market: 24.76 0 (0%)

Fundamental Rating

5

Overall IMAX gets a fundamental rating of 5 out of 10. We evaluated IMAX against 73 industry peers in the Entertainment industry. IMAX has an average financial health and profitability rating. IMAX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

IMAX had positive earnings in the past year.
IMAX had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: IMAX reported negative net income in multiple years.
Of the past 5 years IMAX 4 years had a positive operating cash flow.
IMAX Yearly Net Income VS EBIT VS OCF VS FCFIMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

IMAX has a better Return On Assets (3.77%) than 76.71% of its industry peers.
IMAX has a Return On Equity of 10.23%. This is amongst the best in the industry. IMAX outperforms 82.19% of its industry peers.
IMAX has a better Return On Invested Capital (6.88%) than 78.08% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IMAX is significantly below the industry average of 23.22%.
The last Return On Invested Capital (6.88%) for IMAX is above the 3 year average (4.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.77%
ROE 10.23%
ROIC 6.88%
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
IMAX Yearly ROA, ROE, ROICIMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

Looking at the Profit Margin, with a value of 9.04%, IMAX belongs to the top of the industry, outperforming 84.93% of the companies in the same industry.
IMAX's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 18.00%, IMAX belongs to the best of the industry, outperforming 89.04% of the companies in the same industry.
IMAX's Operating Margin has declined in the last couple of years.
IMAX's Gross Margin of 56.88% is fine compared to the rest of the industry. IMAX outperforms 65.75% of its industry peers.
IMAX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18%
PM (TTM) 9.04%
GM 56.88%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
IMAX Yearly Profit, Operating, Gross MarginsIMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IMAX is destroying value.
IMAX has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, IMAX has less shares outstanding
Compared to 1 year ago, IMAX has a worse debt to assets ratio.
IMAX Yearly Shares OutstandingIMAX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
IMAX Yearly Total Debt VS Total AssetsIMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 1.92 indicates that IMAX is not a great score, but indicates only limited risk for bankruptcy at the moment.
IMAX's Altman-Z score of 1.92 is fine compared to the rest of the industry. IMAX outperforms 64.38% of its industry peers.
IMAX has a debt to FCF ratio of 4.75. This is a neutral value as IMAX would need 4.75 years to pay back of all of its debts.
IMAX's Debt to FCF ratio of 4.75 is fine compared to the rest of the industry. IMAX outperforms 69.86% of its industry peers.
A Debt/Equity ratio of 0.87 indicates that IMAX is somewhat dependend on debt financing.
IMAX's Debt to Equity ratio of 0.87 is on the low side compared to the rest of the industry. IMAX is outperformed by 60.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 4.75
Altman-Z 1.92
ROIC/WACC0.99
WACC6.94%
IMAX Yearly LT Debt VS Equity VS FCFIMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

IMAX has a Current Ratio of 2.33. This indicates that IMAX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of IMAX (2.33) is better than 80.82% of its industry peers.
A Quick Ratio of 2.02 indicates that IMAX has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.02, IMAX is doing good in the industry, outperforming 79.45% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.33
Quick Ratio 2.02
IMAX Yearly Current Assets VS Current LiabilitesIMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 18.82% over the past year.
Measured over the past years, IMAX shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.17% on average per year.
IMAX shows a small growth in Revenue. In the last year, the Revenue has grown by 1.25%.
IMAX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.30% yearly.
EPS 1Y (TTM)18.82%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%44.44%
Revenue 1Y (TTM)1.25%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%3.06%

3.2 Future

IMAX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.83% yearly.
Based on estimates for the next years, IMAX will show a small growth in Revenue. The Revenue will grow by 6.72% on average per year.
EPS Next Y22.74%
EPS Next 2Y21.19%
EPS Next 3Y15.62%
EPS Next 5Y13.83%
Revenue Next Year11.38%
Revenue Next 2Y8.51%
Revenue Next 3Y6.72%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IMAX Yearly Revenue VS EstimatesIMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
IMAX Yearly EPS VS EstimatesIMAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 24.51, IMAX is valued on the expensive side.
Based on the Price/Earnings ratio, IMAX is valued cheaper than 83.56% of the companies in the same industry.
IMAX's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.48.
IMAX is valuated rather expensively with a Price/Forward Earnings ratio of 17.74.
Based on the Price/Forward Earnings ratio, IMAX is valued cheaply inside the industry as 80.82% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.04, IMAX is valued a bit cheaper.
Industry RankSector Rank
PE 24.51
Fwd PE 17.74
IMAX Price Earnings VS Forward Price EarningsIMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

78.08% of the companies in the same industry are more expensive than IMAX, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, IMAX is valued a bit cheaper than the industry average as 78.08% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 22.73
EV/EBITDA 11.95
IMAX Per share dataIMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of IMAX may justify a higher PE ratio.
IMAX's earnings are expected to grow with 15.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.08
PEG (5Y)N/A
EPS Next 2Y21.19%
EPS Next 3Y15.62%

More info and screens

0

5. Dividend

5.1 Amount

IMAX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IMAX CORP

NYSE:IMAX (8/8/2025, 8:04:00 PM)

After market: 24.76 0 (0%)

24.76

+0.11 (+0.45%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)07-24 2025-07-24/bmo
Earnings (Next)10-28 2025-10-28
Inst Owners91.41%
Inst Owner Change0.07%
Ins Owners19.45%
Ins Owner Change0.94%
Market Cap1.33B
Analysts80
Price Target34.22 (38.21%)
Short Float %10.25%
Short Ratio4.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.07%
Min EPS beat(2)11.91%
Max EPS beat(2)20.24%
EPS beat(4)3
Avg EPS beat(4)19.46%
Min EPS beat(4)-6.42%
Max EPS beat(4)52.13%
EPS beat(8)7
Avg EPS beat(8)69.57%
EPS beat(12)9
Avg EPS beat(12)28.75%
EPS beat(16)11
Avg EPS beat(16)16.57%
Revenue beat(2)1
Avg Revenue beat(2)-0.21%
Min Revenue beat(2)-1.46%
Max Revenue beat(2)1.04%
Revenue beat(4)1
Avg Revenue beat(4)-4.03%
Min Revenue beat(4)-11.37%
Max Revenue beat(4)1.04%
Revenue beat(8)3
Avg Revenue beat(8)-0.35%
Revenue beat(12)6
Avg Revenue beat(12)1.29%
Revenue beat(16)7
Avg Revenue beat(16)2.04%
PT rev (1m)0.87%
PT rev (3m)4.37%
EPS NQ rev (1m)-2.55%
EPS NQ rev (3m)-1.24%
EPS NY rev (1m)-0.61%
EPS NY rev (3m)-9.12%
Revenue NQ rev (1m)-2.45%
Revenue NQ rev (3m)-2.44%
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)-0.71%
Valuation
Industry RankSector Rank
PE 24.51
Fwd PE 17.74
P/S 3.67
P/FCF 22.73
P/OCF 17.31
P/B 4.16
P/tB 5.97
EV/EBITDA 11.95
EPS(TTM)1.01
EY4.08%
EPS(NY)1.4
Fwd EY5.64%
FCF(TTM)1.09
FCFY4.4%
OCF(TTM)1.43
OCFY5.78%
SpS6.74
BVpS5.96
TBVpS4.15
PEG (NY)1.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.77%
ROE 10.23%
ROCE 8.68%
ROIC 6.88%
ROICexc 8.05%
ROICexgc 11.79%
OM 18%
PM (TTM) 9.04%
GM 56.88%
FCFM 16.16%
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
ROICexc(3y)4.84%
ROICexc(5y)N/A
ROICexgc(3y)7.01%
ROICexgc(5y)N/A
ROCE(3y)5.33%
ROCE(5y)N/A
ROICexcg growth 3Y113.18%
ROICexcg growth 5Y-5.75%
ROICexc growth 3Y103.14%
ROICexc growth 5Y-8.28%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
F-Score7
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 4.75
Debt/EBITDA 2.22
Cap/Depr 30.7%
Cap/Sales 5.07%
Interest Coverage 250
Cash Conversion 61.51%
Profit Quality 178.66%
Current Ratio 2.33
Quick Ratio 2.02
Altman-Z 1.92
F-Score7
WACC6.94%
ROIC/WACC0.99
Cap/Depr(3y)25.16%
Cap/Depr(5y)18.94%
Cap/Sales(3y)4.33%
Cap/Sales(5y)3.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.82%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%44.44%
EPS Next Y22.74%
EPS Next 2Y21.19%
EPS Next 3Y15.62%
EPS Next 5Y13.83%
Revenue 1Y (TTM)1.25%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%3.06%
Revenue Next Year11.38%
Revenue Next 2Y8.51%
Revenue Next 3Y6.72%
Revenue Next 5YN/A
EBIT growth 1Y52.22%
EBIT growth 3Y108.21%
EBIT growth 5Y-9.36%
EBIT Next Year233.22%
EBIT Next 3Y52.46%
EBIT Next 5Y31.14%
FCF growth 1Y63.61%
FCF growth 3YN/A
FCF growth 5Y-7.57%
OCF growth 1Y58.66%
OCF growth 3Y126.45%
OCF growth 5Y-4.76%